{"id":"td-alone","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Injection site pain, redness, or swelling"},{"rate":"5-15","effect":"Fever"},{"rate":"5-10","effect":"Myalgia"},{"rate":"5-10","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL430074","moleculeType":"Small molecule","molecularWeight":"1769.69"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Td vaccine contains inactivated toxins (toxoids) from Clostridium tetani and Corynebacterium diphtheriae. These toxoids are unable to cause disease but retain immunogenicity, triggering the adaptive immune system to produce protective antibodies and cellular immunity against tetanus and diphtheria toxins. This provides long-term protection against these potentially fatal bacterial infections.","oneSentence":"Td is a toxoid-based vaccine that provides immunization against tetanus and diphtheria by stimulating antibody production against inactivated bacterial toxins.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:11:17.705Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tetanus prophylaxis and immunization"},{"name":"Diphtheria prophylaxis and immunization"}]},"trialDetails":[{"nctId":"NCT07472790","phase":"PHASE1","title":"A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma","status":"NOT_YET_RECRUITING","sponsor":"Beijing Bio-Targeting Therapeutics Technology Co., Ltd","startDate":"2026-03-31","conditions":"High-grade Glioma","enrollment":15},{"nctId":"NCT03650114","phase":"PHASE3","title":"Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2018-12-28","conditions":"Relapsing Multiple Sclerosis","enrollment":1882},{"nctId":"NCT06254326","phase":"PHASE1","title":"ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2024-09-19","conditions":"Recurrent Oligodendroglioma, Progressive Oligodendroglioma","enrollment":12},{"nctId":"NCT07444645","phase":"NA","title":"PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-01","conditions":"Tumor, Liver","enrollment":20},{"nctId":"NCT05294588","phase":"PHASE2","title":"Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-18","conditions":"Gonorrhea Male","enrollment":65},{"nctId":"NCT07354061","phase":"PHASE1, PHASE2","title":"Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)","status":"NOT_YET_RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2026-01-10","conditions":"NSCLC (Non-small Cell Lung Cancer)","enrollment":20},{"nctId":"NCT06514898","phase":"PHASE1","title":"Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-05-05","conditions":"Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma","enrollment":12},{"nctId":"NCT07173920","phase":"NA","title":"Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD","status":"RECRUITING","sponsor":"Peking University Sixth Hospital","startDate":"2025-09-08","conditions":"Tardive Dyskinesia, Repetitive Transcranial Magnetic Stimulation","enrollment":62},{"nctId":"NCT06946238","phase":"NA","title":"Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)","status":"RECRUITING","sponsor":"IRCCS San Raffaele","startDate":"2025-07-25","conditions":"Breast Cancer","enrollment":311},{"nctId":"NCT03396575","phase":"PHASE1","title":"Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-07-17","conditions":"Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma","enrollment":11},{"nctId":"NCT02158858","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies","status":"COMPLETED","sponsor":"Constellation Pharmaceuticals","startDate":"2014-07-16","conditions":"Myelofibrosis, Leukemia, Myelocytic, Acute, Myelodysplastic/Myeloproliferative Neoplasm","enrollment":336},{"nctId":"NCT05609994","phase":"PHASE1","title":"ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas","status":"RECRUITING","sponsor":"Katy Peters, MD, PhD","startDate":"2025-07-15","conditions":"Low Grade Glioma of Brain","enrollment":48},{"nctId":"NCT06142955","phase":"NA","title":"Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-04-30","conditions":"Autism Spectrum Disorder","enrollment":60},{"nctId":"NCT03589768","phase":"PHASE2","title":"Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-01-24","conditions":"Clostridium Difficile Immunisation, Diphtheria, Diphtheria Immunisation","enrollment":399},{"nctId":"NCT06852443","phase":"NA","title":"Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)","status":"RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2025-04-01","conditions":"Prevention, Well Being, Sexual Behavior","enrollment":180},{"nctId":"NCT06169163","phase":"","title":"Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2023-12-01","conditions":"Oesophageal Squamous Cell Carcinoma, Oesophageal Cancer","enrollment":518},{"nctId":"NCT03688178","phase":"PHASE2","title":"DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab","status":"ACTIVE_NOT_RECRUITING","sponsor":"Annick Desjardins, MD","startDate":"2020-08-26","conditions":"Glioblastoma","enrollment":43},{"nctId":"NCT06284395","phase":"","title":"Two Schemes Response in Multiple Myeloma","status":"RECRUITING","sponsor":"Hospital General de Mexico","startDate":"2023-11-20","conditions":"Response, Acute Phase, Survivorship","enrollment":83},{"nctId":"NCT06525948","phase":"PHASE4","title":"Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2024-07-30","conditions":"Aplastic Anemia, Transfusion-dependent Anemia","enrollment":54},{"nctId":"NCT06472570","phase":"NA","title":"Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours","status":"RECRUITING","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2019-10-26","conditions":"Head and Neck Cancer","enrollment":80},{"nctId":"NCT06447285","phase":"NA","title":"Early, Objective Detection of Autism.","status":"NOT_YET_RECRUITING","sponsor":"SensoDetect","startDate":"2024-05-29","conditions":"Autism Spectrum Disorder","enrollment":300},{"nctId":"NCT03927222","phase":"PHASE2","title":"Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma","status":"TERMINATED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2019-09-30","conditions":"Glioblastoma","enrollment":6},{"nctId":"NCT05801133","phase":"PHASE2","title":"Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors","status":"RECRUITING","sponsor":"Hubei Cancer Hospital","startDate":"2023-03-31","conditions":"Lung Cancer","enrollment":41},{"nctId":"NCT05480462","phase":"PHASE3","title":"Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.","status":"UNKNOWN","sponsor":"IBSS Biomed S.A.","startDate":"2022-12-12","conditions":"Diphtheria, Tetanus","enrollment":200},{"nctId":"NCT02193347","phase":"PHASE1","title":"IDH1 Peptide Vaccine for Recurrent Grade II Glioma","status":"COMPLETED","sponsor":"Katy Peters, MD, PhD","startDate":"2016-01-28","conditions":"Brain Cancer, Brain Neoplasm, Primary, Brain Neoplasms, Recurrent","enrollment":24},{"nctId":"NCT06144775","phase":"","title":"A Kinematic Analysis of Motor Planning and Movement Execution of Children With Autism Spectrum Condition","status":"UNKNOWN","sponsor":"Istituto per la Ricerca e l'Innovazione Biomedica","startDate":"2022-10-01","conditions":"Autism, Autism Spectrum Disorder","enrollment":60},{"nctId":"NCT04879199","phase":"NA","title":"Stop Tip-toeing Around Toe-walking","status":"COMPLETED","sponsor":"University Children's Hospital Basel","startDate":"2021-08-11","conditions":"Spastic Cerebral Palsy (sCP)","enrollment":46},{"nctId":"NCT05004090","phase":"","title":"Emotional Regulation in Children With ND: the Role of Genomic Variation, Proteomic Patterns, and Early Experience","status":"UNKNOWN","sponsor":"IRCCS Eugenio Medea","startDate":"2021-04-07","conditions":"Neurodevelopmental Disabilities, Emotional Regulation, Epigenetics","enrollment":248},{"nctId":"NCT01216202","phase":"","title":"Sexual Function and Wellbeing in Males With Rectal Cancer","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2010-04","conditions":"Rectal Cancer","enrollment":178},{"nctId":"NCT02366728","phase":"PHASE2","title":"DC Migration Study for Newly-Diagnosed GBM","status":"COMPLETED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2015-10-12","conditions":"Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma","enrollment":64},{"nctId":"NCT05003752","phase":"PHASE1, PHASE2","title":"Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"German Oncology Center, Cyprus","startDate":"2021-08-01","conditions":"Prostate Adenocarcinoma, Radiation Toxicity","enrollment":40},{"nctId":"NCT02563145","phase":"NA","title":"Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents","status":"COMPLETED","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2015-10","conditions":"Aggression, Conduct Disorder","enrollment":37},{"nctId":"NCT04376372","phase":"","title":"Forced Lefthandedness in Neonatal Brachial Plexus Palsy (NBPP) Children","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-05-01","conditions":"Neonatal Brachial Plexus Palsy","enrollment":82},{"nctId":"NCT03916055","phase":"NA","title":"Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2019-04-26","conditions":"Tourette's Disorder, Persistent (Chronic) Motor or Vocal Tic Disorder","enrollment":221},{"nctId":"NCT03434704","phase":"PHASE2","title":"Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole","status":"COMPLETED","sponsor":"Ciceri Fabio","startDate":"2018-06-18","conditions":"Transplant-Related Hematologic Malignancy, Leukemia, Acute, Myelodysplastic Syndromes","enrollment":10},{"nctId":"NCT02864368","phase":"PHASE1","title":"Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens","status":"TERMINATED","sponsor":"Eric Thompson, M.D.","startDate":"2016-12-07","conditions":"Glioblastoma, Glioblastoma Multiforme","enrollment":27},{"nctId":"NCT02578082","phase":"PHASE1","title":"Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2015-12","conditions":"Renal Impairment","enrollment":16},{"nctId":"NCT02581592","phase":"PHASE1","title":"Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2015-11","conditions":"Hepatic Impairment","enrollment":16},{"nctId":"NCT03400033","phase":"PHASE3","title":"Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-09-05","conditions":"Anaemia","enrollment":407},{"nctId":"NCT04616521","phase":"NA","title":"Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label Study","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2021-01-01","conditions":"Parkinson Disease","enrollment":1000},{"nctId":"NCT04618939","phase":"PHASE3","title":"To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children","status":"COMPLETED","sponsor":"Boryung Biopharma Co., Ltd.","startDate":"2016-10-20","conditions":"Diphtheria, Tetanus","enrollment":218},{"nctId":"NCT03063736","phase":"EARLY_PHASE1","title":"Entolimod, an Adjuvant for Vaccine Augmentation","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2017-12-08","conditions":"Substance Use Disorders","enrollment":40},{"nctId":"NCT02485587","phase":"NA","title":"Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents","status":"COMPLETED","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2015-09","conditions":"Aggression, Conduct Disorder, Oppositional Defiant Disorder","enrollment":28},{"nctId":"NCT00746486","phase":"PHASE3","title":"Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)","status":"TERMINATED","sponsor":"Dr. Falk Pharma GmbH","startDate":"2009-02","conditions":"Primary Biliary Cirrhosis","enrollment":62},{"nctId":"NCT03552445","phase":"PHASE4","title":"Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine","status":"COMPLETED","sponsor":"Korea University Guro Hospital","startDate":"2013-11-01","conditions":"Tetanus, Diphtheria, Pneumococcal Infections","enrollment":462},{"nctId":"NCT00081939","phase":"PHASE2","title":"UARK 2003-33, Total Therapy III","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2004-01","conditions":"Multiple Myeloma","enrollment":303},{"nctId":"NCT02716428","phase":"PHASE2","title":"A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection","status":"COMPLETED","sponsor":"Trek Therapeutics, PBC","startDate":"2016-05","conditions":"Hepatitis C Viral Infection, Chronic Hepatitis C, Hepatitis C (HCV)","enrollment":25},{"nctId":"NCT00414635","phase":"PHASE4","title":"FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment","status":"COMPLETED","sponsor":"Community Research Initiative of New England","startDate":"2006-08","conditions":"HIV Infections","enrollment":60},{"nctId":"NCT01502761","phase":"PHASE1, PHASE2","title":"Intra-arterial Magnesium Administration for Acute Stroke","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2012-03","conditions":"Acute Stroke","enrollment":4},{"nctId":"NCT02946190","phase":"PHASE2","title":"The PertADO Geneva Trial","status":"COMPLETED","sponsor":"Siegrist Claire-Anne","startDate":"2016-10-27","conditions":"Pertussis","enrollment":60},{"nctId":"NCT01390363","phase":"NA","title":"Study of Adolescent Immunization Recall Systems","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2010-05-01","conditions":"Immunization, Reminder Systems","enrollment":420},{"nctId":"NCT00536120","phase":"PHASE4","title":"The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis","status":"COMPLETED","sponsor":"Biogen","startDate":"2008-01","conditions":"Multiple Sclerosis","enrollment":60},{"nctId":"NCT01294605","phase":"PHASE4","title":"Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-04","conditions":"Acellular Pertussis, Tetanus, Diphtheria","enrollment":460},{"nctId":"NCT01277705","phase":"PHASE3","title":"Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-01","conditions":"Tetanus, Diphtheria, Acellular Pertussis","enrollment":806},{"nctId":"NCT00601835","phase":"PHASE4","title":"Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2004-05","conditions":"Diphtheria, Tetanus","enrollment":3651},{"nctId":"NCT02645890","phase":"PHASE1","title":"Study to Compare the Safety and Pharmacokinetics of CKD-397","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2015-11","conditions":"Benign Prostatic Hyperplasia","enrollment":36},{"nctId":"NCT01119703","phase":"","title":"Vaccine Hyporesponse in Healthy Elderly Participants (MK-0000-131 AM2)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-07","conditions":"Vaccine Response Impaired","enrollment":174},{"nctId":"NCT00857311","phase":"PHASE1","title":"MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-05","conditions":"Hepatitis C","enrollment":17},{"nctId":"NCT01993173","phase":"PHASE3","title":"Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2013-11","conditions":"Diphtheria, Tetanus, Pertussis","enrollment":1440},{"nctId":"NCT02361866","phase":"PHASE3","title":"To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2014-05","conditions":"Bacterial Infections","enrollment":376},{"nctId":"NCT00128219","phase":"PHASE2","title":"Prevention of GBS Colonization Via Immunity","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-07","conditions":"Beta Haemolytic Streptococcal Infection","enrollment":667},{"nctId":"NCT00297856","phase":"","title":"Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-03","conditions":"Diphtheria, Tetanus, Acellular Pertussis","enrollment":10000},{"nctId":"NCT01839994","phase":"PHASE3","title":"Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer","status":"UNKNOWN","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2013-06","conditions":"Prostate Cancer","enrollment":350},{"nctId":"NCT01134484","phase":"PHASE3","title":"VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)","status":"UNKNOWN","sponsor":"Michele Cavo","startDate":"2006-05","conditions":"Multiple Myeloma","enrollment":480},{"nctId":"NCT01338688","phase":"","title":"The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2008-10","conditions":"Tetanus","enrollment":250},{"nctId":"NCT01267058","phase":"PHASE3","title":"Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1997-09","conditions":"Diphtheria, Pertussis, Tetanus","enrollment":550},{"nctId":"NCT01262924","phase":"PHASE3","title":"Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1997-10","conditions":"Diphteria, Tetanus and Pertussis","enrollment":116}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11493,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Td alone","genericName":"Td alone","companyName":"Korea University Guro Hospital","companyId":"korea-university-guro-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"Td is a toxoid-based vaccine that provides immunization against tetanus and diphtheria by stimulating antibody production against inactivated bacterial toxins. Used for Tetanus prophylaxis and immunization, Diphtheria prophylaxis and immunization.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}